[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE92770T1 - Mittel zum nachweis einer fibrinolytischen wirkung. - Google Patents

Mittel zum nachweis einer fibrinolytischen wirkung.

Info

Publication number
ATE92770T1
ATE92770T1 AT90912800T AT90912800T ATE92770T1 AT E92770 T1 ATE92770 T1 AT E92770T1 AT 90912800 T AT90912800 T AT 90912800T AT 90912800 T AT90912800 T AT 90912800T AT E92770 T1 ATE92770 T1 AT E92770T1
Authority
AT
Austria
Prior art keywords
antibody
fibrinolytic
fibrinolytic enzyme
detecting
increased
Prior art date
Application number
AT90912800T
Other languages
English (en)
Inventor
Johan Selmer
Niels Tromholt
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE92770T1 publication Critical patent/ATE92770T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/972—Plasminogen activators
    • G01N2333/9726—Tissue plasminogen activator

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT90912800T 1989-08-18 1990-08-16 Mittel zum nachweis einer fibrinolytischen wirkung. ATE92770T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK408289A DK408289D0 (da) 1989-08-18 1989-08-18 Diagnostisk reagens
PCT/DK1990/000210 WO1991002546A1 (en) 1989-08-18 1990-08-16 A reagent for the detection of fibrinolytic activity

Publications (1)

Publication Number Publication Date
ATE92770T1 true ATE92770T1 (de) 1993-08-15

Family

ID=8129992

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90912800T ATE92770T1 (de) 1989-08-18 1990-08-16 Mittel zum nachweis einer fibrinolytischen wirkung.

Country Status (18)

Country Link
US (1) US5165912A (de)
EP (1) EP0487594B1 (de)
JP (1) JPH04507254A (de)
KR (1) KR920703120A (de)
AT (1) ATE92770T1 (de)
AU (1) AU639940B2 (de)
CA (1) CA2065147A1 (de)
CZ (1) CZ280904B6 (de)
DD (1) DD297064A5 (de)
DE (1) DE69002769T2 (de)
DK (2) DK408289D0 (de)
ES (1) ES2058931T3 (de)
FI (1) FI920669A0 (de)
IE (1) IE65525B1 (de)
IL (1) IL95407A (de)
NO (1) NO920624L (de)
NZ (1) NZ234937A (de)
WO (1) WO1991002546A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7544500B2 (en) * 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US6964764B2 (en) * 1999-11-13 2005-11-15 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US6355243B1 (en) 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
US20080167544A1 (en) * 2006-12-01 2008-07-10 Cold Spring Diagnostics, Inc. Compositions And Methods For Locating An Internal Bleeding Site
EP2297317A4 (de) * 2008-06-04 2011-12-07 Talecris Biotherapeutics Inc Zusammensetzung, verfahren und kit zur herstellung von plasmin
JP5789521B2 (ja) 2009-03-03 2015-10-07 グリフオルス・セラピユーテイクス・インコーポレーテツドＧｒｉｆｏｌｓ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． プラスミノーゲンを製造するための組成物、方法およびキット；ならびにそれから製造されるプラスミン

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61501321A (ja) * 1984-01-23 1986-07-03 インスティテュト・フォ−・エネジテクニク たんぱく様物質標識用テクネチウム９９ｍ組成物およびその使用方法
US4659839A (en) * 1984-10-10 1987-04-21 Mallinckrodt, Inc. Coupling agents for radiolabeled antibody fragments
CA1285223C (en) * 1986-11-10 1991-06-25 New England Deaconess Hospital Detection of vascular disease

Also Published As

Publication number Publication date
DK408289D0 (da) 1989-08-18
US5165912A (en) 1992-11-24
CA2065147A1 (en) 1991-02-19
CZ404790A3 (en) 1996-01-17
AU6285990A (en) 1991-04-03
EP0487594A1 (de) 1992-06-03
KR920703120A (ko) 1992-12-17
IL95407A0 (en) 1991-06-30
DE69002769D1 (de) 1993-09-16
FI920669A0 (fi) 1992-02-17
CZ280904B6 (cs) 1996-05-15
NO920624D0 (no) 1992-02-17
WO1991002546A1 (en) 1991-03-07
IE65525B1 (en) 1995-11-01
IL95407A (en) 1994-07-31
EP0487594B1 (de) 1993-08-11
DK0487594T3 (da) 1994-01-03
DD297064A5 (de) 1992-01-02
JPH04507254A (ja) 1992-12-17
NO920624L (no) 1992-02-17
DE69002769T2 (de) 1993-12-02
NZ234937A (en) 1991-11-26
IE902977A1 (en) 1991-02-27
AU639940B2 (en) 1993-08-12
ES2058931T3 (es) 1994-11-01

Similar Documents

Publication Publication Date Title
SE8902638L (sv) Stabiliserade protein- eller peptidkonjugat
DE68928946D1 (de) Verfahren zum aufspüren von diagnostischen oder therapeutischen mitteln durch antikörper
AU6264686A (en) Antibody complexes of hapten-modified diagnostic or therapeutic agents
ATE100209T1 (de) Antikoerper verwendende diagnostische methoden.
MY108526A (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
ES2061459T3 (es) Procedimiento de ensayo de substancias fisiologicamente activas.
ATE260931T1 (de) Verfahren zur identifizierung von verbindungen mit verminderter systemischer aktivität
ES8605476A1 (es) Un procedimiento para preparar un derivado de acido benzoico.
JPS5441191A (en) Glucose-oxygen sensitive electrode
ATE92770T1 (de) Mittel zum nachweis einer fibrinolytischen wirkung.
DE3478958D1 (en) Protein conjugates of penicilloic acid, their preparation and use
NO177463C (no) STLV-III-beslektede polypeptider, diagnostiske prövesett og in vitro analysefremgangsmåte for påvisning av anti-HIV-2-antistoffer i kroppsvæskepröve
ES557404A0 (es) Procedimiento de dosificacion de anticuerpos dirigidos contra toxinas bacterianas.
FI881122A (fi) Menetelmä tyvikalvoproteiinien eristämiseksi ihmis- ja eläinkudoksista
AU7160887A (en) Antiparatypical antibodies, their use for detecting and treating auto-immune diseases
DK112290A (da) Vaevsplasminogenaktivator-variant
ES8707798A1 (es) Un procedimiento para analizar una muestra de tejido para determinar la presencia de antigeno de la hepatitis no a no b
DE69027441D1 (en) Ribozymenhemmer
ATE4637T1 (de) Pentadecapeptid, verfahren zu seiner herstellung und immunisierendes mittel.
IE873143L (en) HOMOGENEOUS SHEEP TllTS AS AN INTERMEDIATE FOR THE¹PREPARATION OF HUMAN Tllts, AND THE USE THEREOF
FR2603702A1 (fr) Methode de titrage des isoenzymes de transaminase glutamique oxalacetique dans un serum humain
AU7692987A (en) Reagent kit, its use and diagnostic process for the detection of hpasp(human pancreatic specific protein)
EP0241000A3 (de) Verfahren zur Bestimmung von Komplementen
ES2084056T3 (es) Procedimiento para la deteccion de activadores de plasminogeno, sus inhibidores o estimuladores.
RU98112436A (ru) Способ определения фибринолитической активности мочи

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee